1. Ha YC. Epidemiology of osteoporosis. J Korean Med Assoc. 2016; 59:836–841.
2. Jeon YK, Kim BH, Kim IJ. The diagnosis of osteoporosis. J Korean Med Assoc. 2016; 59:842–846.
Article
3. Min YK. Pharmacologic treatment of osteoporosis. J Korean Med Assoc. 2016; 59:847–856.
Article
4. Park SY, Lee SH, Kang CH. Surgical or nonsurgical treatment of osteoporotic fractures. J Korean Med Assoc. 2016; 59:857–865.
Article
5. Choi YJ, Oh HJ, Kim DJ, Lee Y, Chung YS. The prevalence of osteoporosis in Korean adults aged 50 years or older and the higher diagnosis rates in women who were beneficiaries of a national screening program: the Korea National Health and Nutrition Examination Survey 2008-2009. J Bone Miner Res. 2012; 27:1879–1886.
Article
6. Yoo JH, Moon SH, Ha YC, Lee DY, Gong HS, Park SY, Yang KH. Osteoporotic fracture: 2015 position statement of the Korean Society for Bone and Mineral Research. J Bone Metab. 2015; 22:175–181.
Article
7. Lee SR, Ha YC, Kang H, Park YG, Nam KW, Kim SR. Morbidity and mortality in Jeju residents over 50-years of age with hip fracture with mean 6-year follow-up: a prospective cohort study. J Korean Med Sci. 2013; 28:1089–1094.
Article
8. Assessment of fracture risk and its application to screening for postmenopausal osteoporosis: report of a WHO study group. World Health Organ Tech Rep Ser. 1994; 843:1–129.
9. Yang KH, Min BW, Ha YC. Atypical femoral fracture: 2015 position statement of the Korean Society for Bone and Mineral Research. J Bone Metab. 2015; 22:87–91.
Article
10. Adler RA, El-Hajj Fuleihan G, Bauer DC, Camacho PM, Clarke BL, Clines GA, Compston JE, Drake MT, Edwards BJ, Favus MJ, Greenspan SL, McKinney R Jr, Pignolo RJ, Sellmeyer DE. Managing osteoporosis in patients on long-term bisphosphonate treatment: report of a Task Force of the American Society for Bone and Mineral Research. J Bone Miner Res. 2016; 31:16–35.
Article